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Abstract
Introduction: Cardiopulmonary exercise testing (CPET), the gold standard of cardiopulmonary evaluation, is used to determine
VO2 levels at different aerobic exercise training intensities; however, it may not be feasible to conduct CPET in all clinical settings.
Aims: To compare the heart rate reserve (HRR) and percent of 220-age methods for prescribing cycle ergometry exercise
intensity using heart rate (HR) against the HRs obtained during a CPET in adults undergoing treatment for acute leukemia (AL).
Methods: In this exploratory study, part of a larger randomized controlled trial, 14 adults with AL completed CPET on a cycle
ergometer with indirect calorimetry within 96 hr of admission to a cancer hospital to determine VO2peak and HR corresponding
to low (40% VO2peak), moderate (60% VO2peak), and high (75% VO2peak) exercise intensities. Analyses of variance were used to
compare estimated HR for each intensity level using the HRR and percent of 220-age methods with HR determined via VO2peak.
Results: HR corresponding to low-intensity exercise differed significantly across all three methods (p ≤ .05). No significant
differences were observed between HR estimated via the percent of 220-age method and determined via VO2peak at moderate
(100+ 8 and 113+ 24 bpm, p ¼ .122) or high intensities (125+ 10 and 123+ 25 bpm, p ¼ .994). Conclusion: In adults with
AL, HR-based methods for defining aerobic exercise intensities should be used with caution. At low intensity, neither should be
used, while at moderate and high intensities, the percent of 220-age equation might serve as an adequate substitute for CPET.
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Acute leukemia (AL) is a type of blood cancer that disrupts the
production and/or maturation of hematopoietic cells in the bone
marrow. In 2015, it accounted for more than 27,000 cancer
cases in the United States (American Cancer Society [ACS],
2015). Acute myeloid leukemia (AML) and acute lymphoblas-
tic leukemia (ALL) are commonly treated via high-intensity
induction chemotherapy. Treatment is successful in saving the
lives of 65% of AML patients and 80% of ALL patients, but the
5-year survival rate is significantly lower in leukemia patients
(only 30% for AML and 40% for ALL patients) when com-
pared to other types of cancers such as breast and prostate
(ACS, 2015).
Shortening the time between diagnosis and treatment com-
pletion is important for achieving remission and increases the
rate of survival in AL patients (ALPs). However, severity of
symptoms and side effects can decrease treatment adherence,
for example, cancer-related fatigue that can lead to decreased
fitness capacity and difficulties performing the activities of
daily living and decreased health-related quality of life (Bryant,
Walton, & Phillips, 2015; Bryant, Walton, Shaw-Kokot,
Mayer, & Reeve, 2015). A few studies have examined potential
benefits of exercise training in leukemia patients and have
achieved successful outcomes in the alleviation of treatment-
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related symptoms, particularly fatigue (Alibhai et al., 2012;
Battaglini et al., 2009; Chang et al., 2008; Klepin et al.,
2011). There has been limited research, however, in determin-
ing the most effective exercise prescription paradigm (i.e.,
mode, duration, intensity, frequency, and timing within treat-
ment) to maximize the benefits in patients with hematological
cancers. Schmitz et al. (2010), authors of the ‘‘American Col-
lege of Sports Medicine Roundtable on Exercise Guidelines for
Cancer Survivors,’’ called for researchers to continue to
explore different training regimens as well as the effects of
exercise in other cancer populations.
At this time, the recommendations for exercise are general-
ized for the cancer population and are the same as the Physical
Activity Guidelines for Americans, including the recommenda-
tion of 150 min of moderate intensity exercise per week
(Schmitz et al., 2010). In the AL population, however, the pre-
scription of exercise is challenging due not only to the intense
treatment schedules and side effects but also to the inability of
hospitals to perform accurate cardiorespiratory testing and use
the results to prescribe exercise training intensity level. Cardio-
pulmonary exercise testing (CPET) to determine VO2peak is the
gold standard for cardiopulmonary evaluation and is often used
for determining exercise training intensities in different popula-
tions including cancer patients (Jones, Eves, Haykowsky, Joy, &
Douglas, 2008). However, not every clinic or hospital has the
equipment or personnel infrastructure to conduct and use the
results of CPET to prescribe exercise intensity to their cancer
patients. Thus, exercise intensity prescription varies based on
availability of testing methods. In previous studies, exercise pre-
scriptions for these patients have varied significantly, even
though all represented attempts to be in the range of low- to
moderate-intensity prescriptions: resting heart rate (RHR) þ
30 bpm (Chang et al., 2008), 40–50% of heart rate reserve
(HRR; Battaglini et al., 2009), and 60–75% of HRR (Alibhai
et al., 2012).
For the purpose of practicality in these hospital settings, the
HRR method and percent of 220-age equation have been used
to prescribe exercise intensity without the benefit of CPET. In
addition, in most exercise intervention research programs, for
both supervised and unsupervised settings, heart rate (HR) has
been used as a relatively easy and inexpensive way to monitor
exercise intensity because of its practicality. No study, how-
ever, has examined the precision of using practical HR-based
methods of exercise intensity determination such as the HRR or
the percent of 220-age equation in ALPs initiating treatment,
which leads to the simple questions of how well these methods
of exercise intensity determination compare to the gold stan-
dard CPET in ALPs and whether the HR used for the determi-
nation of exercise intensity differs by cancer diagnosis or
treatment type. Therefore, it is paramount that researchers con-
duct additional studies to allow for the development of more
specific exercise plans for patients with cancer, including those
with hematological malignancies (Battaglini, 2011).
In the present study, we compared HR training targets
calculated using the HRR (often referred to as the Karvonen
formula) and percent of 220-age equations against the HRs
obtained directly from CPET for the determination of aerobic
exercise intensity in newly diagnosed ALPs undergoing induc-
tion chemotherapy. The HR values from each of the three
methods were compared at three different exercise intensity
levels: low (40% of VO2peak), moderate (60% of VO2peak), and
high (75% of VO2peak).
Materials and Methods
Participants
Study participants were 14 ALPs recruited from an ongoing
larger trial at a North Carolina cancer hospital within 3 days
of admission for treatment to the hematology oncology unit.
A study coordinator informed patients about the study. If a
patient expressed interest in participating, the coordinator
asked the patient’s medical oncologist to evaluate her or his
eligibility to participate based on review of the patient’s med-
ical history and initial tests performed throughout the admis-
sion process and the following study inclusion/exclusion
criteria: Participants were to be adults 21 years old, newly
diagnosed with AML or ALL, admitted to begin induction
chemotherapy with an expected hospital stay of 3–4 weeks,
able to speak and understand English, and enrolled to partici-
pate in the parent study, Exercise and Quality of Life in Leu-
kemia/Lymphoma Patients (EQUAL). They should not have
cardiovascular disease; acute or chronic respiratory disease;
acute or chronic bone, muscle, or joint abnormalities; altered
mental state, dementia, or any other psychological condition
that would prevent understanding of informed consent; another
active malignancy; and active bleeding, acute thrombosis,
ischemia, hemodynamic instability, or uncontrolled pain. After
the medical oncologist cleared patients to participate in the
study, we asked patients to sign an informed consent form
approved by the University Biomedical Institutional Review
Board prior to participating in any study activities.
All hematology patients admitted to the hospital undergo an
electrocardiogram as well as an echocardiogram (ECHO) and
multigated acquisition scan (MUGA) for the assessment of
cardiovascular function prior to beginning treatment. We used
the results of these tests as a screening tool for participation in
the study as a mean to minimize the potential for an adverse
event during the CPET.
Instrumentation
Participants performed all CPETs with indirect calorimetry on
a mechanically braked cycle ergometer (Monark 874E, Gote-
borg, Sweden) within 96 hr of being admitted at an inpatient
hematology oncology unit of the hospital. To determine oxy-
gen uptake, we measured expired gases via a portable meta-
bolic gas analysis system (Cosmed Portable K4b2, Rome,
Italy). A hematology–oncology nurse assessed blood pressure
(BP) using standard hospital equipment in the patient’s room
prior to the CPET. We collected HR values using a Polar tele-
metry system (Polar Electro Inc., Lake Success, NY). At the
end of each stage of CPET and at the end of the test, we used
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the Rate of Perceived Exertion Original Borg Scale to monitor
rate of perceived exertion (RPE; Borg, 1982).
CPET
We used standard CPET procedures, adjusting the equipment
to fit each patient, to determine VO2peak. Prior to beginning the
cycling protocol, patients rested on the bike while we collected
2 min of resting metabolic data via expiratory gas analysis.
Patients then cycled for 2 min at a resistance of 0 W as a
warm-up, with the test starting immediately following the
warm-up period.
The workload was initially 25 W and increased 5–20 W/min,
depending on the physical state of the patient (Jones et al., 2008).
Specifically, we determined workload increments for the
remainder of the test based upon the patient’s medical history
and metabolic response during the warm-up. Test termination
criteria were volitional fatigue, achievement of a respiratory
exchange ratio (RER) of greater than 1.10, or limitation by
symptoms. Symptoms that would end a test immediately
included chest pain, a BP response considered abnormal to exer-
cise conditions, dizziness, or nausea.
During the test, we recorded HR every 10 s and RPE at the
end of every minute before increase to the next workload. We
collected VO2 data every 4 s over 30 s intervals and used the
average of the three highest values of VO2 during the last
minute of the test to determine VO2peak. Following the test,
patients could choose to rest or cool down by pedaling at
10 W until HR returned to under 120 bpm.
Determination of Exercise Intensity Level Using CPET,
HRR, and the Percent of 220-Age Methods
Both the HRR method and the percent of 220-age equation are
commonly used for the determination of aerobic exercise inten-
sity in healthy and clinical populations due to their practicality
and ease of use. Both methods rely on a calculation of the
percentage of the predicted maximum HR that corresponds to
each chosen intensity level (e.g., low intensity [40% of
VO2peak] is determined by multiplying with .40 in these two
equations). For these equations, HR is assumed to increase in a
linear fashion, as intensity of exercise increases to the maxi-
mum (Robergs & Roberts, 1997).
For the present study, using the VO2peak determined from
the CPET, we calculated VO2 values for low intensity (40%
VO2peak), moderate intensity (60% VO2peak), and high intensity
(75% VO2peak) exercise. By averaging the raw VO2 data col-
lected every 4 s throughout the course of the test over 30-s
intervals, we were able to match HR values collected every
10 s throughout the test to the VO2 corresponding to each
exercise intensity. Figure 1 is a representation from one subject
showing how we identified HR levels corresponding to each
exercise intensity level using VO2peak obtained during the
CPET. We then used the HRR and percent of 220-age methods
to determine HR levels corresponding to the same three exer-
cise intensities (40%, 60%, and 75% of VO2peak). The formula
for the HRR method is (HRmax  RHR) % intensity þ RHR,
where HRmax is maximum heart rate, calculated using the
220-age equation, RHR is resting heart rate, and % intensity
is the percent of VO2peak that corresponds to each exercise
intensity level. The formula for the percent of 220-age method
is (220-age in years)  % intensity.
Statistical Analysis
Using the G*power (version 3.1) analysis program, a sample
size of 14 patients provided 70% power to detect an effect size
of 0.60. A mean difference of 6 bpm and an SD of the differ-
ence of 10 bpm were used for the power calculation. Descrip-
tive statistics of mean and SD are presented for age, height,
weight, resting HR, and maximum HR achieved during the
CPET. An a level set a priori at .05 was used for all analyses.
All statistical analyses were performed using SPSS software
version 22.0 for Mac OS (IBM Solutions, Durham, NC). Three
models of aerobic exercise intensity determination calculated
at the three different exercise intensities were compared using
one-way within-subjects analysis of variance (ANOVA)models.
If the ANOVA models were significant, post hoc analyses
using the Sidak method to identify where significant differ-
ences in HR occurred between methods were employed.
Results
The purpose of this study was to compare the HR values com-
puted using the HRR method and the percent 220-age equation
to HR levels obtained from CPET for the determination of aero-
bic exercise intensity in ALPs undergoing induction treatment.
We included 14 ALPs (12 with AML and 2 with ALL) in the
analyses. Participant characteristics are presented in Table 1.
For low-intensity exercise, the HRR method significantly
overestimated HR when compared to the HR obtained using
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Figure 1. Heart rate (HR) versus VO2 from the cardiopulmonary
exercise testing (CPET) used to determine VO2peak of one bone mar-
row transplant patient who completed the same testing procedure
used in the present study. The VO2 values represent raw VO2 data
recorded every 4 s during the CPET and averaged over 30-s intervals.
The HR data were recorded every 10 s during the CPET.
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the percentage of VO2peak method (HRR ¼ 112 + 12 bpm,
%VO2¼ 100+ 22 bpm, p¼ .000), and the percent of 220-age
equation significantly underestimated HR when compared to
the percentage of VO2peak method (percent of 220-age ¼ 67+
6, p ¼ .026). The results of the analyses for all HRs calculated
using all three methods for low intensity (40% of VO2peak) are
presented in Figure 2.
At moderate-intensity exercise, there was a significant dif-
ference between the HR levels obtained using the HRR method
and the percentage of VO2peak test (HRR ¼ 130 + 12 bpm,
%VO2 ¼ 113 + 24 bpm, p ¼ .004), but there was no signif-
icant difference between the HR estimated via the percent of
220-age method (100 + 8 bpm) and HR measured at 60% of
VO2peak (p ¼ .122). The results of the analyses for all HRs
calculated using all three methods for moderate intensity
(60% of VO2peak) are presented in Figure 3.
At high-intensity aerobic exercise, the HRR method once
again significantly overestimated HR when compared to the
percentage of VO2peak test (HRR ¼ 144 + 12 bpm, %VO2
¼ 124 + 25 bpm, p ¼ .003), while the HR estimated using
the percent of 220-age equation (125+ 10 bpm) again did not
differ significantly from that determined using %VO2peak (p ¼
.994). The results of the analyses for all HRs calculated using
all three methods for high intensity (75% of VO2peak) are pre-
sented in Figure 4.
Discussion
This was the first study to compare indirect HR training target
estimation methods to an objective and direct measurement of
HR at various training intensities. The comparison of all three
methods across several intensity levels allowed us to examine
the accuracy of such calculated methods when compared to the
gold standard method of VO2 measurement via CPET.
Low Intensity
At the low-intensity exercise level of 40% of VO2peak, results
indicated that both HR estimation methods differed from the
VO2peak method, with the HRR overestimating and percent of
Table 1. Participant Characteristics.
Subject Age Type of Leukemia Weight (kg) Height (cm) Resting Heart Rate (bpm)
1 34 AML 69.8 155 95
2 58 AML 90.3 187.9 59
3 64 AML 86.5 165 98
4 40 AML 128 198.1 81
5 57 AML 102.2 184.2 77
6 43 AML 95.5 182 86
7 28 ALL 116.6 164 93
8 67 AML 97.7 188 67
9 67 AML 47.5 153 69
10 57 AML 74.1 160 57
11 64 AML 74.1 163 57
12 69 AML 93 187 89
13 60 AML 94.8 182.5 60
14 39 ALL 60.6 188 75
Mean+ SD
All subjects 53 + 14 87.9+ 21.4 175.6+ 14.8 76+ 15
Min–Max
All subjects 28–69 47.5–128.0 153.0–198.1 57–98
Note. ALL ¼ acute lymphoblastic leukemia; AML ¼ acute myeloid leukemia; Min ¼ minimum; Max ¼ maximum; SD ¼ standard deviation.
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Figure 2. Heart rate (bpm) for each subject at low-intensity aerobic
exercise (40% of VO2peak, observed during cardiopulmonary exercise
testing) and calculated for this intensity using the heart rate reserve
(HRR) and percent of 220-age methods. The 14 subjects are ranked
along the x-axis by age, with the youngest ranked #1 and continuing to
the oldest at #14.
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220-age underestimating HR. The overestimation of HR calcu-
lated with the HRR method may be due to an increase in fluids
or other physiological alterations due to the disease or treat-
ment that can affect HR. The underestimation from the percent
of 220-age equation may be due to the fact that resting HR is
not included in the calculation. Participants’ resting HRs were
often above the value estimated for 40% of VO2peak intensity
using the percent of 220-age equation. Based on these results,
neither method is an acceptably accurate method for prescrib-
ing low-intensity aerobic exercise in this patient population.
Moderate Intensity
At the moderate-intensity exercise level of 60% of VO2peak,
there was no significant difference between the HR estimated
using the percent of 220-age equation and the HR derived from
the VO2peak test. However, the difference of 13 bpm between the
two methods is clinically significant; therefore, these results
should be interpreted with caution. This difference in bpm is
large enough to significantly compromise the utility of the exer-
cise prescription, as it represents underprescription of an inten-
sity that is targeted to promoting desirable changes in certain
physiological parameters, such as cardiorespiratory fitness.
During moderate-intensity exercise, the cardiorespiratory
system is working harder to supply the muscles with oxygen
more quickly in order to maintain a higher level of force pro-
duction. The increased cardiac output required at this intensity
may cause HRs to become more similar to those predicted by
the HRR and percent of 220-age equations (Brooks, Fahey, &
Baldwin, 2005).
The HRRmethod again overestimated HRwhen compared to
the HR determined via VO2peak, just as it did at low intensity. The
reasons for this overestimation are likely the sameas theywere for
low intensity: a decreased ability to carry oxygen as a result of the
disease or the myelosuppression from chemotherapy.
High Intensity
At the high-intensity exercise level of 75% of VO2peak, we
found results similar to those at moderate intensity, in that there
was no significant difference between HR derived using the
percent of 220-age method and HR determined from
the VO2peak test. At high intensity, the difference between the
mean HR derived using the percent 220-age method and mean
HR determined from the VO2peak test was only 2 bpm, a sig-
nificant heterogeneity reduction in HR responses between sub-
jects, possibly due to the higher HR needed for subjects to be
able to maintain a higher level of power output. As seen at the
other intensities, the HRR method overestimated HR when
compared to the VO2peak method of measuring HR.
Implications for Research and Practice
Although the statistical outcomes at the moderate- and high-
intensity levels were more favorable than at the low intensity
level, with HRs derived by the percent of 220-age equation not
differing significantly from those measured using the gold stan-
dard CPET method, the overall picture when looking at indi-
vidual participants is much different. Not only is there wide
variation between HRs derived using each of the two prediction
methods and the HRs from the VO2peak test, but this variation is
not systematic or consistent between or even within partici-
pants. These variable differences across intensities suggest that
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Figure 3. Heart rate (bpm) for each subject at moderate intensity
aerobic exercise (60% of VO2peak, observed during cardiopulmonary
exercise testing) and calculated for this intensity using the heart rate
reserve (HRR) and percent of 220-age methods. The 14 subjects are
ranked along the x-axis by age, with the youngest ranked #1 and
continuing to the oldest at #14.
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Figure 4. Heart rate (bpm) for each subject at high-intensity aerobic
exercise (75% of VO2peak, observed during cardiopulmonary exercise
testing) and calculated for this intensity using the heart rate reserve
(HRR) and percent of 220-age methods. The 14 subjects are ranked
along the x-axis by age, with the youngest ranked #1 and continuing to
the oldest at #14.
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another method or scale might need to be included in the deter-
mination of exercise intensity in this specific population.
As patients go through treatment, their exercise tolerance
changes daily due to infections, fluids shifts, treatment side
effects, and the disease process itself. For the purposes of prac-
ticality and scalability, without compromising prescription
accuracy, a subjective parameter based on the daily physical
well-being of the patient might be a more accurate tool for
prescribing intensity, for example, the RPE. The physiological
changes due to the treatment and its side effects may change the
daily ability of these cancer patients to exercise, and a subjec-
tive measure used to ascertain how they feel and how able they
are to perform on any given day may assist trainers and help
care providers to quantify and monitor their exercise intensity
until a better method of exercise quantification is determined.
In terms of direct application in a hospital setting, based on
these results, neither the HRR method nor the percent of
220-age equation appears to be a reliable method for the deter-
mination of exercise intensity due to the large variation in HR
between patients at each level of intensity. The average differ-
ence of 13 bpm between the HR predicted by the percent of
220-age equation and the actual HR from the VO2 method is
clinically relevant, especially for ALPs who experience
changes in exercise tolerance depending on their cancer and
treatments. Based on the results of this study, we recommend
that, for this patient population, HR-based equations and HR in
general should not be used exclusively to determine exercise
intensity. As discussed earlier, including other parameters
along with HR such as self-reported outcomes (e.g., levels of
fatigue, pain) and perhaps even other physiological parameters
that are monitored daily by nurses and could be checked prior
to training, including hematocrit, hemoglobin, absolute neutro-
penic count, fevers, and so on, as well as information on the
patient’s perception of levels of physical exertion during exer-
cise may help guide exercise specialist on the adjustment of
training intensity. To this time, researchers have used only HR
and RPE in previous studies to prescribe exercise intensity,
with this study being the first to look at the accuracy of using
HR-based methods for the determination of exercise intensity
in leukemia patients. Therefore, we can make no definitive
statement as to the recommended method for prescribing exer-
cise intensity in the ALP population at this time.
A variety of physiological factors can affect HR, including
fluid levels, stress, medications, and others. Maintenance of
overall physical function during the various phases of treatment
for AL is very important for assisting patients to better tolerate
treatment and potentially attain more favorable long-term prog-
noses (Wood et al., 2013). The attainment of a training
response is not always possible; however, for patients experi-
encing fewer treatment-related side effects, a training progres-
sion aimed at producing more prominent positive response
should be explored. Future studies should examine the most
appropriate and precise method for prescribing the training
dose to promote a more specific physiological response. It may
be that, for this cancer population, functional training involving
more of a resistance training focus would be more appropriate.
The cardiovascular component of the overall fitness and health
of the patient could be maintained with light doses of aerobic
training for which the intensity determination could be based
on each patient’s capacity as determined on a daily basis.
Future studies should, therefore, examine different training
protocols, with different exercise intensities, along with the
examination of more appropriate ways of quantifying exercise
intensity, especially aerobic training.
Study Limitations
The sample size in the present study was small. A larger sample
size might allow for the drawing of more definite conclusions
about the prescription of aerobic exercise intensity using HR.
There was a large variation in participant age, 28–69 years old,
and there were large differences in RHR values, from 57 to
98 bpm. RHR values may have differed due to factors such as
medications and initiation of treatment prior to completion of the
VO2peak test. Of the 14 participants, 1 was on medication a week
prior to enrollment which could have altered HR and BP
responses during testing. The participant had been prescribed
this medication due to the levels of stress and anxiety the patient
exhibited after diagnosis rather than to address any cardiovas-
cular comorbidity. The medical oncologist had cleared this
patient for participation, and this patient experienced no adverse
effects during testing. Nevertheless, this patient’s HR response
to exercise could have been affected by the medication even
though we observed no abnormal response during testing. It is
also important to note that this evaluation used only one single
bout of exercise performed to maximal effort. A familiarization
testing session where participants learn and experience a CPET
prior to the day of testing is always a desirable procedure to
maximize the chance for a subject to produce their maximal
effort on the test day. When participants are familiarized with
the testing procedures ahead of time, they usually become less
anxious, are used to the testing equipment, and are more prone to
perform at their best. Due to the nature and logistics of leukemia
treatments, where treatments may need to be started immedi-
ately, and the likelihood of patients’ physical states changing
significantly from day to day, a familiarization session prior to
testing is usually not feasible in this population.
Since we developed this study as a preliminary examination
using data from a larger trial designed to evaluate other out-
comes, a future study could focus specifically on HR and
potential alterations HR may exhibit during treatment. The
results of the present study could be used to inform the calcula-
tion of power for future trials aimed at confirming or refuting
these preliminary findings.
Conclusion
The HRR method and the percent of 220-age equation are com-
monly used methods for calculating HR values corresponding to
varying levels of aerobic exercise intensity in different popula-
tions (da Cunha, Farinatti, & Midgley, 2011; Engels, Zhu, &
Moffatt, 1998). Although the use of HR is a fairly easy and
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practical method for quantifying exercise intensity, it is impor-
tant to keep in mind that HR is sensitive to daily changes. In
cancer patients, whose physical status can change day to day due
to treatment and its side effects, HR responses can vary even
more significantly than in apparently healthy individuals.
Based on the results of this study, in adults with AL, HR-
based methods for the determination of aerobic exercise inten-
sities should be used with caution. For low-intensity exercise,
neither percent of 220-age nor HRR was accurate in compari-
son to direct determination of HR from VO2, while at moderate
and high intensities, the percent of 220-age equation produced
HR values similar to those directly determined using VO2peak
in some, but not all, patients. However, though the differences
between HR values derived from the percent of 220-age equa-
tion and those directly determined from VO2 at moderate and
high intensities were not statistically significant, at moderate
intensity this difference did appear to be clinically significant.
Our results lead us to the conclusion that neither the HRR
method nor the percent of 220-age equation should be the sole
method used to determine exercise intensity in this population.
We recommend that future studies explore other parameters
and methods to be used alone or in conjunction with HR to
better determine physical exertion (exercise intensity) prescrip-
tions for patients undergoing induction chemotherapy.
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